-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903.P1.33 903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I

Symposia: Health Services and Quality Improvement: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Kelly Pugh, MD1, Ronit Juthani, MD2*, Pallawi Torka, MD3 and Nina Neuendorff, MD4*

1Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
2Saint Vincent Hospital, Worcester, MA
3Lymphoma Service, Department of Medicine, MSKCC, New York, NY
4Marien Hospital Herne-Universitätsklinikum der Ruhr-Universität Bochum, Herne, Germany

Chantal Cassis, MD1, Victoria Korsos, MD2,3*, Saima Ahmed, PhD4*, Vasiliki Bitzas, PhD5*, Sheena Heslip, NP4*, Sarah Matarasso Greenfeld, MD4*, Rayan Kaedbey4 and Sarit E. Assouline, MD6

1Jewish General Hospital, McGill University, Montreal, QC, CAN
2Jewish General Hospital, Montreal, Canada
3McGill University, Montreal, QC, Canada
4Jewish General Hospital, McGill University, Montreal, QC, Canada
5Jewish General Hospital, McGill University, Montreal, Canada
6Jewish General Hospital, McGill University, Westmount, QC, Canada

Somya Khare, BS1, Rachel J. Cook, MD, MS2, Amrita Desai, MD, MPH1, Arpita Gandhi, MD1, Kelli Goslee, BS1*, Brandon Hayes-Lattin, MD1, Curtis A Lachowiez, MD3, Jessica T. Leonard, MD4, Richard T. Maziarz, MD4, Gabrielle Meyers, MD1*, Laura F. Newell, MD1, Jennifer N. Saultz, DO1, Ronan T. Swords, MD, PhD, FRCP, FRCPath1, Elie Traer, MD, PhD1 and Eneida R Nemecek, MD, MSc, MBA1

1Knight Cancer Institute, Oregon Health & Science University, Portland, OR
2Oregon Health & Science University, Portland, OR
3Knight Cancer Institute, Oregon Health & Science University, Houston, TX
4Knight Cancer Institute, Oregon Health and Science University, Portland, OR

Noor Kundu1*, Dylan Gowlett-Park, BSc2*, August Lin3,4*, Sila Usta, BSc2,5*, Tina Khazaee, MEng, MSc2,5*, Katarina Czibere, BSc2*, Alexandra Misura, BSc2,5*, Olga Bigun, MD2,5*, Betty Wong, MSc6*, Samuel Matsumura, BSc6*, Hubert Tsui, MD, PhD, FRCPC7 and Signy Chow, MD, MSc, FRCPC8,9

1Sunnybrook Research Institute, University of Toronto/Sunnybrook Health Sciences Centre, Toronto, ON, Canada
2Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
3University of Western Ontario, London, ON, Canada
4University of Toronto/Sunnybrook Health Sciences Centre, Toronto, ON, Canada
5Precision Diagnostics and Therapeutics Program, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
6Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
7Division of Hematological Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Science Centre, University of Toronto, Toronto, ON, Canada
8Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
9Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada

Felipe Magalhães Furtado, MD, PhD1, Maura Valerio Ikoma Colturato2*, Fabiola Gevert3*, Maria Daniela Holthausen Perico, MD4*, Berta S Santos, MD5*, Ana Claudia Carramaschi Villela Soares6*, Danielle Marchetti Vitelli Avelar7*, Elizabeth XISTO Souto, MD8*, Miriam Perlingeiro Beltrame9,10*, Nydia Bacal, MD, MBA11*, Patricia Fernanda Rosa de Siqueira12*, Robéria Mendonça Pontes, MSc, PhD13*, Raquel Arrieche Fernandes14*, Tharsis Cardoso Ferreira dos Santos15*, Fernanda Marquezotti16*, Bernardete Evangelho Gomes17*, Andressa Oliveira Martin Wagner18*, Ana Paula Fortunato Dametto, MD19*, Camila Marques Bertolucci2*, Alef Rafael Severino20*, Mary E.D. Flowers, MD21, Fernando Barroso, MD22,23* and Afonso Celso Vigorito, MD, PhD24*

1Sabin Diagnóstico e Saúde, Brasilia, BRA
2Hospital Amaral Carvalho, Jau, Brazil
3Associação Hospitalar de Proteção a Infância Dr Raul Carneiro, Curitiba, Brazil
4Centro de Hematologia e Hemoterapia de Santa Catarina – HEMOSC - Fundação de Apoio ao Hemosc / Cepon –, Florianopolia, Brazil
5DASA, Rio de Janeiro, Brazil
6Dasa, Rio de Janeiro, Brazil
7Hematológica - Oncoclínicas, Belo Horizinte, Belgium
8Laboratory Flow Cytometry, Albert Einstein Hospital, Sao Paulo, São Paulo, Brazil
9Erasto Gaertner, Curitiba, RN, BRA
10Erasto Gaertner, Curitiba, SE, BRA
11Laboratory flow cytometry, Albert Einstein HOspital, sao paulo, Brazil
12Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG) / UFRJ - Laboratório de Citometria de Fluxo, Rio de Janeiro, Brazil
13Hospital da Criança de Brasília, Brasilia, BRA
14Laboratório de Análise Clínicas (Setor de Imunofenotipagem) - Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil
15Laboratório de Citometria do Hemocentro de São José do Rio Preto, São José do Rio Preto, Brazil
16Laboratório de Imunologia de Transplantes - Setor: Citometria de Fluxo Santa Casa Porto Alegre, Porto Alegre, Brazil
17Laboratório de Imunologia do Serviço de Atividades Laboratoriais do CEMO / Inca, Rio de Janeiro, Brazil
18Laboratorio Santa Luzia/ DASA, Florianópolis, Brazil
19Sollutio Diagnósticos, Indaiatuba, Brazil
20Hospita Amaral Carvalho, Jau, Brazil
21Fred Huch, Seattle, WA
22TERAPIA CELULAR, HOSPITAL MONTE KLINIKUM, FORTALEZA, Brazil
23Federal University of Ceara, Fortaleza, Brazil
24Hematology and Transfusion Medicine Center, University of Campinas - UNICAMP, Campinas, Brazil

Marie Michele Sainvil, MD1,2, Melissa Lowe, MS3*, Delaney Underwood, MS4*, Yan Li, PhD3*, Tomi F. Akinyemiju, PhD, MS.2,5*, Taewoong Choi, MD2,6, Cristina Gasparetto, MD2,6*, Mitchell Horwitz, MD2,6, Gwynn D. Long, MD2,6*, Richard Lopez, MD2,6*, Stefanie Sarantopoulos, MD, PhD2,6, Edwin Alyea III, MD2,6*, Nelson J. Chao, MD2,6, Thomas W. LeBlanc, MD, MA, MS2,5,6, Yubin Kang, MD2,6, Sendhilnathan Ramalingam, MD6, Anthony D. Sung, MD4 and Sanghee Hong, MD2,6

1Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, durham, NC
2Duke Cancer Institute, Duke University School of Medicine, Durham, NC
3Duke Cancer Institute Biostatistics Shared Resource, Duke University, Durham, NC
4Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham
5Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
6Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC

Aditya Sanjeevi, MD, MBBS1, Daniel Idoate Jose Domench2*, Aniket Vijay Rao, MD2*, Basant Eltaher, MD1* and Muhammad Hammad Sharif2*

1Department of Internal Medicine, Rochester General Hospital, Rochester, NY
2Rochester General Hospital, Rochester, NY

Elizabeth T. Loggers, MD, PhD1*, James Fausto, MD2*, Matthew Givens, MD1*, Mei-Ean Yeow, BMBCh3*, Reena V. Jayani, MD, MSCI4, Hassan B Alkhateeb, MD5*, Laura A Schoenherr, MD6*, Michael W. Rabow, MD7*, Mark B Juckett, M.D., M.H.C.M.8, George Carrum, MD9, Joseph Uberti, MD, PhD10, Kyle Neale, DO11*, Santiago Lopez, MD12*, Diana Martins-Welch, MD12*, Jeanette G Ferrer, DO13*, Laura S Rhee, DO3*, Drew A Rosielle, MD14*, Susan McInnes, MD11*, Jason A Webb, MD15*, Rachel J. Cook, MD, MS16, Elisheva Newman, MD17*, Ronald Sobecks, MD18, Laura Johnston, MD19 and Mohamed Sorror, MD, MSc20

1Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA
3Division of Community Internal Medicine, Geriatrics and Palliative Care, Mayo Clinic, Rochester, MN
4Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
5Division of Hematology, Mayo Clinic, Rochester, MN
6Division of Palliative Medicine, University of California San Francisco, San Francisco, CA
7Division of Palliative Medicine, University of California, San Francisco, San Francisco, CA
8Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
9The Methodist Hospital, Houston, TX
10Karmanos Cancer Institute, Detroit, MI
11Department of Palliative and Supportive Care, Cleveland Clinic, Cleveland, OH
12Hofstra Northwell School of Medicine, Hempstead, NY
13Houston Methodist Hospital, Houston, TX
14Palliative Care Program, Departments of Family Medicine & Community Health and Internal Medicine, University of Minnesota Medical School, Minneapolis, MN
15Oregon Health and Sciences University, Portland, OR
16Oregon Health & Science University, Portland, OR
17Karmanos Cancer Center, Detroit, MI
18Blood and Marrow Transplant, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
19Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
20Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Ksenya Shliakhtsitsava, MD1, Kendra Parkinson, BSN, RN, CPHON2*, Irina Stanasel, MD3* and Jason Jarin, MD4*

1Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX
2Center for Cancer and Blood Disorders, Children's Health, Dallas, TX
3Children's Health/Department of Pediatrics/Division of Pediatric Urology, University of Texas Southwestern Medical Center, Dallas, TX
4Children's Health/Division Director of Pediatric and Adolescent Gynecology, University of Texas Southwestern Medical Center, Dallas, TX

Carolyn Mead-Harvey1*, Brie N Noble, MS1*, Claire Yee2*, Gina L. Mazza, PhD1*, Blake Langlais, MS1*, Sheetal Patel3*, Peter Trask4*, Lauren Rogak5*, Ethan Basch, MD, MSc6*, Amylou C Dueck, PhD1 and Gita Thanarajasingam, MD7

1Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
2Mayo Clinic, Phoenix, AZ
3Genentech, Inc., San Francisco
4Genentech, Inc., South San Francisco, CA
5Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale
6UNC Chapel Hill, Chapel Hill, NC
7Division of Hematology, Mayo Clinic, Rochester, MN

Tonya Cox, BSN, RN1, Nicole Zahradka, PhD2*, Casey Martin, MS3*, Betsy Blunk, BSN, RN1*, Rocky L. Billups, MS1, Sarah Meissner, BSN, RN4*, Hannah Sowell, RN5*, Stephanie Larson, MSN, RN6*, Meredith Perez, BSN, RN7*, Aravind Ramakrishnan, MD8, Paul Shaughnessy, MD9, Ashleigh Smith, BSN, RN8*, Michael T. Tees, MD, MPH10, Jeremy Pantin, MD7, Benjamin Zaniello, MD, MPH11*, Navneet Majhail, MD, MS, FASTCT1 and Minoo Battiwalla, MD1

1Sarah Cannon Transplant and Cellular Therapy Network, HCA Healthcare, Nashville, TN
2Best Buy Health, Boston, MA
3Genospace, Inc., Boston, MA
4The Colorado Blood Cancer Institute a part of the Sarah Cannon Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
5Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital, HCA Healthcare, San Antonio, TX
6Sarah Cannon Transplant & Cellular Therapy Program, HCA Healthcare, Nashville, TN
7Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
8Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX
9Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX
10Colorado Blood Cancer Institute, a part of Sarah Cannon Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
11Best Buy Health, Boston

*signifies non-member of ASH